Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,727.50
Bid: 1,727.50
Ask: 1,728.00
Change: -1.00 (-0.06%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Wed, 22nd Jul 2020 15:59

Thursday 23 July 
Tate & Lyle PLCTrading Statement
Unilever PLCHalf Year Results
G4S PLCHalf Year Results
AJ Bell PLCQ3 Results
Countryside Properties PLCHalf Year Results
Brewin Dolphin Holdings PLCQ3 Results
Howden Joinery Group PLCHalf Year Results
Sage Group PLCQ3 Results
RELX PLCHalf Year Results
Daily Mail & General Trust PLCHalf Year Results
Croda International PLCHalf Year Results
IG Group Holdings PLCFull Year Results
Beazley PLCHalf Year Results
Abcam PLCTrading Statement
Johnson Matthey PLCTrading Statement
Hellical PLCTrading Statement
GetBusy PLCHalf Year Results
Cohort PLCFull Year Results
Polymetal International PLCQ2 Production
Petra Diamonds LtdTrading Statement
Friday 24 July 
Hotel Chocolat Group PLCTrading Statement
IMI PLCInterim 2020 Results
Vodafone Group PLCQ1 2021 Trading Statement
CVS Group PLCTrading Statement
Centrica PLCInterim 2020 Results
Airtel Africa PlcQ1 2021 Results
PearsonHalf Year Results
Monday 27 July 
Ryanair Holdings PLCQ1 2021 Results
JTC PLCTrading Statement
Ascential PLCHalf Year Results
Tuesday 28 July 
Greggs PLCHalf Year Results
Sanne Group PLCTrading Statement
IMImobile PLCFull Year Results
IG Design Group PLCFull Year Results
Yourgene Health PLCFull Year Results
Quartix Holdings PLCHalf Year Results
Vivo Energy PLCHalf Year Results
MITIE Group PLCTrading Statement
MoneySupermarket.com Group PLCHalf Year Results
Tyman PLCHalf Year Results
Reckitt Benckiser Group PLCHalf Year Results
Greencore Group PLCTrading Statement
Elementis PLCHalf Year Results
Sabre Insurance Group PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Games Workshop GroupFull Year Results
Fresnillo PLCHalf Year Results
St James's Place PLCHalf Year Results
Wednesday 29 July 
Aptitude Software Group PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
Aveva Group PLCTrading Statement
Barclays PLCHalf Year Results
Breedon Group PLCHalf Year Results
Devro PLCHalf Year Results
Dignity PLCHalf Year Results
Drax Group PLCHalf Year Results
FDM Group Holdings PLCHalf Year Results
GlaxoSmithKline PLCHalf Year Results
Horizon Discovery Group PLCHalf Year Results
Hyve Group PLCTrading Statement
Jupiter Fund Management PLCHalf Year Results
Lancashire Holdings PLCQ2 Results
Next PLCTrading Statement
Premier Foods PLCTrading Statement
Primary Health PropertiesHalf Year Results
Rathbone BrothersHalf Year Results
Rio Tinto PLCHalf Year Results
Seplat Petroleum Development Co PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Taylor WimpeyHalf Year Results
Tullow OilTrading Statement
Unite Group PLCHalf Year Results
Victoria PLCFull Year Results
Walker Greenbank PLCTrading Statement
Weir Group PLCHalf Year Results
Wizz Air Holdings PLCQ1 Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.